Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

28 Nov 2013

Abstract excerpt

As of October 2013, H7N9 avian influenza viruses caused 137 human cases with 45 fatalities. Recent studies revealed that only minor adaptive changes are required for H7N9 viruses to become pandemic. Vaccination is a primary measure to protect population from severe disease and reduce the impact of epidemics and pandemics on public health. Several H7N9 candidate vaccine viruses have been generated and are now...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Respiratory viral infections research
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24308582
DOI: 10.1586/14760584.2014.864564

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?PMID 24308582Read ↗

220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.Semantic proximity Read ↗

An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in HumansSemantic proximity Read ↗

A consensus-hemagglutinin-based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus.Semantic proximity Read ↗

Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virusSemantic proximity Read ↗

Cross-conservation of T-cell epitopesSemantic proximity Read ↗

A Recombinant Viruslike Particle Influenza A (H7N9) VaccineSemantic proximity Read ↗

Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses.Semantic proximity Read ↗

Human Cytotoxic T Lymphocytes Directed to Seasonal Influenza A Viruses Cross-React with the Newly Emerging H7N9 VirusSemantic proximity Read ↗

Structural and Molecular Characterization of the Hemagglutinin from the Fifth-Epidemic-Wave A(H7N9) Influenza Viruses.Semantic proximity Read ↗

Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.Semantic proximity Read ↗

Modification of neutralizing epitopes of hemagglutinin for the development of broadly protective H9N2 vaccine.Semantic proximity Read ↗

The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.